Picture of Clean Power Hydrogen logo

CPH2 Clean Power Hydrogen News Story

0.000.00%
gb flag iconLast trade - 00:00
EnergyHighly SpeculativeMicro CapSucker Stock

REG - Clean Power Hydrogen - Corporate Update and Proposed Fundraising

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250731:nRSe2879Ta&default-theme=true

RNS Number : 2879T  Clean Power Hydrogen  31 July 2025

 

THIS ANNOUNCEMENT, INCLUDING THE APPENDIX AND INFORMATION CONTAINED HEREIN, IS
RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN
PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED
STATES, CANADA, JAPAN, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH
AFRICA, THE REPUBLIC OF IRELAND, ANY MEMBER STATE OF THE EEA OR ANY OTHER
JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS
OR REGULATIONS OF THAT JURISDICTION. PLEASE SEE THE IMPORTANT NOTICES AT THE
END OF THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND SHALL NOT CONSTITUTE AN
OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR
OR OTHERWISE ACQUIRE ANY NEW ORDINARY SHARES OF CPH2 IN THE UNITED
STATES, CANADA, JAPAN, AUSTRALIA, NEW ZEALAND,  THE REPUBLIC OF SOUTH
AFRICA, THE REPUBLIC OF IRELAND, ANY MEMBER STATE OF THE EEA OR ANY OTHER
JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE
UNLAWFUL.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE
MARKET ABUSE REGULATION EU NO. 596/2014, AS RETAINED AND APPLICABLE IN
THE UK PURSUANT TO S3 OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR").
UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW
CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

31 July
2025

 

Clean Power Hydrogen plc

("CPH2", the "Company" or the "Group")

 

Operational & Strategic Update and Proposed Fundraising

 

CPH2, the UK-based green hydrogen technology and manufacturing company that
has developed the IP-protected Membrane-Free Electrolyser ("MFE"), is pleased
to provide an update on current operational activities and strategy.

 

CPH2 has made significant technical progress in recent months, culminating in
the announcement of the successful completion of the Site Acceptance Test
("SAT") for its MFE110 electrolyser ("MFE110") at Northern Ireland Water's
("NIW") site in Belfast. The final stage of the SAT was completed and
independently witnessed by Lagan MEICA Limited ("Lagan"), the principal
contractor, and ARUP, representing NIW. Lagan has subsequently noted the
benefits of using high purity oxygen as part of a project which incorporates
an MFE in wastewater treatment, observing a 15% reduction in aeration time, a
31% increase in ammonia removal, and a 13% reduction in energy consumption,
amongst other efficiency gains.

 

The Company recently released a technology white paper that further outlines
the advantages of MFE green hydrogen and oxygen production which can be
accessed on our website here: https://bit.ly/4fppkL9
(https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fbit.ly%2F4fppkL9&data=05%7C02%7CJames.Hobson%40cph2.com%7Cf9289d8d680a444b605008ddcf99b944%7C9f4f5592b10840df9958f10bb6692674%7C0%7C0%7C638894981353137929%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=fI5kO%2FXBLAX6jTvyGdmDgWVgRCDB3I76VMgJQF0DSwM%3D&reserved=0)
.

 

Alongside these technical milestones, the Company has continued to develop
commercial traction with its pipeline, including the signing of a non-binding
Memorandum of Understanding with Constant Energy Ltd, an Irish-based energy
developer involved in the Killala Energy Hub in County Mayo, Ireland. Richard
Scott joined the Company as Chief Commercial Officer to lead the acceleration
of CPH2's Commerciality Phase, driving licensee activation and building the
commercial pipeline further within the growing market space of 'mission
critical' applications that have a need to decarbonise and ensure energy
resilience, where electrification is compromised. These include reliable clean
water supply, data centre uptime, electricity grid support and renewable
energy asset enhancement, life sciences and medical uses, and biomass plant
efficiency. In these sectors CPH2 has a demonstrable and patent protected
technology solution.

 

Four MFE220 electrolyser ("MFE220") units have already been sold to three key
customers with £5m of revenue contracted. The MFE220 is considered the
Company's first commercial product and is a cost and design enhanced version
of the MFE110 currently deployed to NIW, built on the same technology and with
the same user benefits. The Company is currently focused on building its first
MFE220 unit for NIW and is expecting Factory Acceptance Test ("FAT") in Q4
2025 / Q1 2026 with SAT expected to be achieved in H1 2026.

 

In addition, CPH2 has licence agreements in place with Fabrum Solutions
Limited ("Fabrum"), Lisheen H2 Energy Park Limited (trading as "Hidrigin") and
Kenera Energy Solutions Limited ("Kenera"), a subsidiary of Helmerich &
Payne Inc., which enable CPH2 to rapidly scale up to meet demand for its MFE
technology across multiple geographies. The licences for Hidrigin and Kenera
are now activated, with each in receipt of manufacturing and design license
documentation for the MFE220.

 

A copy of the Company's latest corporate presentation is available on the
Company's website at www.cph2.com/investors/.

 

Proposed Fundraising

 

The Company's board of directors has been actively monitoring the delivery of
the Group's strategy and the associated capital requirements against the
funding available to the Company. Accordingly, management continues to
actively explore strategic partnerships with industry and government
stakeholders in additional to non-dilutive funding aligned with economic
impact and energy transition objectives.

 

In order to fund its short-term objective of finalising the commercialisation
of its unique and highly scalable MFE product, the Company is proposing to
raise a minimum of £6.5m by way of a fundraising (the "Fundraising") of new
ordinary shares in the capital of the Company (the "New Shares") at a proposed
price of 5 pence per New Share (the "Issue Price"). The Issue Price represents
a discount of 3.3 per cent. to the volume weighted average price of the
Company's shares in the 20 trading days prior to 30 July 2025 (being the last
business day prior to this announcement) and a discount of 1 per cent. to the
closing middle market price of 5.05 pence on that date.

 

The Fundraising is expected to be carried out by way of a subscription, a
placing (by way of an accelerated book build process) and a retail offer via
the Bookbuild platform in order to enable the Company's retail shareholder
base to participate and to continue to support its growth strategy (the
"Retail Offer"). Further details of the Fundraising will be announced in due
course.

 

The Company has received expressions of interest to participate in the
Fundraising from, and on behalf of, certain existing shareholders and other
investors, including West Hill Capital, Kenera and a number of the directors
of CPH2. Since the Group was founded in 2012, West Hill Capital introduced
investors have invested approximately £18 million to support the development
of CPH2's MFE technology.

 

The net proceeds of the Fundraising will be used to fund the Group's working
capital requirements through to the SAT of its first commercial MFE220 unit
and to accelerate commercial pipeline growth and drive new product sales.

 

Any additional proceeds raised pursuant to the Fundraising will provide
additional working capital support and further strengthen the balance sheet.

 

Whilst the Company has received non-binding indications of interest, there can
be no certainty at this time that the Fundraising will complete on the
proposed terms or at all. Shareholders should note that, in the event that the
Fundraising is not successful and alternative funding is not available on
suitable terms or at all, the amount of working capital available to the
Company will be severely limited. Accordingly, in light of the Company's
existing cash position, the Company would have to severely restrict its costs,
impacting its ability to progress its growth strategy and continue its
operations beyond the end of September 2025.

 

Accordingly, in advance of completion of the Fundraising and pending the
successful SAT of the MFE220, CPH2's CEO, Jon Duffy has agreed to receive 20%
of his salary in New Shares ("Salary Sacrifice Shares") at the Issue Price in
lieu of cash remuneration in order to preserve capital and ensure funds are
directed towards project activities.

 

Jon Duffy, CEO of Clean Power Hydrogen, commented:

 

We are at a pivotal point for the Company and the commercialisation of our
technology and capital is the single biggest constraint we face as a business.
With the appropriate level of further funding, we are confident we will be
able to finalise and deliver the first of our commercial MFE220 units and,
thereafter, accelerate the roll out of our technology to our core target
sectors, driving not only revenues but also shareholder value. In parallel, we
will continue to foster potential strategic partnerships that may bring
additional capital as well as scaling and market penetration expertise.

 

ENDS

 

For more information, please contact:

 

 Clean Power Hydrogen plc                                via Camarco
 Jon Duffy, Chief Executive Officer
 James Hobson, Chief Financial Officer

 Cavendish Capital Markets Limited - NOMAD & Broker
 Neil McDonald                                           +44 (0)131 220 9771
 Peter Lynch                                             +44 (0)131 220 9772
 Adam Rae                                                +44 (0)131 220 9778

 Camarco PR                                              + 44(0) 20 3757 4980
 Owen Roberts
 Kirsty Duff

 

To find out more, please visit: https://www.cph2.com (https://www.cph2.com)

 

Overview of CPH2

 

CPH2 is the holding company of Clean Power Hydrogen Group Limited which has
almost a decade of dedicated research and product development experience. This
experience has resulted in the creation of simple, safe and sustainable
technology which is designed to deliver a modular solution to the hydrogen
production market in a cost-effective, scalable, reliable and long-lasting
manner. The Group's strategic objective is to deliver the lowest LCOH in the
market in relation to the production of green hydrogen. CPH2 is listed on the
AIM market and trades under the ticker LON:CPH2.

Forward-Looking Statements

This announcement contains forward-looking statements. These statements relate
to the Group's future prospects, developments and business strategies.
Forward-looking statements are identified by their use of terms and phrases
such as "potential", "estimate", "expect", "may", "will" or the negative of
such terms and phrases, variations or comparable expressions, including
references to assumptions. The forward-looking statements in this announcement
are based on current expectations and are subject to risks and uncertainties
that could cause actual results to differ materially from those expressed or
implied by those statements. These forward-looking statements speak only as at
the date of this announcement. No statement in this announcement is intended
to constitute a profit forecast or profit estimate for any period. No
representation or warranty is given as to the completeness or accuracy of the
forward-looking statements contained in this Announcement.  Neither the
Directors nor the Company undertake any obligation to update forward-looking
statements other than as required by the AIM Rules or by the rules of any
other securities regulatory authority, whether as a result of new information,
future events or otherwise.

Market Abuse Regulation

Market soundings, as defined in MAR, were taken in respect of the Fundraising,
with the result that certain persons became aware of inside information, as
permitted by MAR. That inside information is set out in this announcement and
has been disclosed as soon as possible in accordance with paragraph 7 of
article 17 of MAR. Therefore, those persons that received inside information
in a market sounding are no longer in possession of inside information
relating to the Company and its securities.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDURVRRVKUBOUR

Recent news on Clean Power Hydrogen

See all news